background
viral
detect
differ
respiratori
sampl
type
children
cystic
fibrosi
cf
facilit
avail
molecular
method
optimum
sampl
strategi
identifi
addit
associ
viral
detect
respiratori
symptom
well
describ
object
studi
goal
compar
molecular
detect
virus
concurr
upper
airway
sputum
sampl
children
cf
describ
rel
frequenc
respiratori
viral
infect
identifi
potenti
clinic
associ
method
conduct
prospect
surveil
studi
children
cf
age
year
upper
airway
sputum
sampl
collect
quarterli
pulmonari
exacerb
test
respiratori
syncyti
viru
rsv
influenza
virus
parainfluenza
virus
type
human
metapneumoviru
coronavirus
rhinovirus
adenovirus
physic
exam
symptom
survey
use
identifi
respiratori
sign
symptom
result
upper
airway
sampl
collect
visit
concord
pcrbase
viral
detect
examin
subset
pair
upper
airway
sputum
sampl
particip
visit
rhinoviru
commonli
detect
viru
overal
rhinoviru
detect
sampl
type
sensit
specif
detect
rhinoviru
sputum
rel
upper
airway
sampl
respect
respiratori
symptom
associ
rhinoviru
detect
includ
increas
cough
increas
nasal
congest
increas
sputum
product
wheez
conclus
rel
high
frequenc
rhinoviru
detect
observ
either
upper
airway
sputum
sampl
clinic
find
suggest
significantassoci
symptom
burden
prior
use
molecular
detect
method
detect
respiratori
virus
detect
rate
respiratori
virus
clinic
specimen
children
cystic
fibrosi
cf
remark
low
viral
detect
patient
popul
complic
multipl
factor
includ
tenaci
respiratori
specimen
inhibit
viral
growth
cell
cultur
bacteri
fungal
overgrowth
contamin
respiratori
specimen
gener
problem
cultiv
difficulttopropag
respiratori
virus
rhinoviru
coronaviru
viral
pathogen
use
potenti
insensit
serolog
assay
hamper
detect
respiratori
viral
infect
patient
popul
nonetheless
associ
respiratori
viral
infect
exacerb
lung
diseas
overal
progress
cf
airway
diseas
appreci
number
year
molecular
diagnost
techniqu
circumv
problem
associ
viral
cultur
children
cf
permit
detect
virus
extrem
difficult
imposs
cultur
even
optim
set
multipl
virus
includ
influenza
parainfluenza
adenoviru
respiratori
syncyti
viru
rsv
clearli
associ
pulmonari
exacerb
worsen
lung
function
children
cf
howev
clinic
symptom
associ
new
respiratori
virus
coronaviru
human
metapneumoviru
well
describ
symptomat
impact
rhinoviru
commonli
detect
viru
cf
patient
perform
prospect
cohort
studi
schoolag
children
cf
compar
respiratori
viru
detect
upper
airway
sputum
sampl
realtim
polymeras
chain
reaction
pcr
detect
respiratori
virus
perform
respiratori
specimen
collect
routin
clinic
visit
pulmonari
exacerb
pair
upper
airway
sputum
sampl
collect
subset
particip
within
larger
cohort
studi
concord
pcrbase
viral
detect
sampl
type
determin
associ
detect
respiratori
virus
clinic
symptom
also
evalu
children
diagnosi
cf
year
age
attend
clinic
seattl
children
hospit
elig
enrol
lung
transplant
recipi
exclud
studi
approv
institut
review
board
seattl
children
hospit
particip
enrol
januari
follow
prospect
year
studi
visit
occur
schedul
quarterli
clinic
visit
pulmonari
exacerb
visit
histori
medic
review
determin
occurr
pulmonari
exacerb
defin
hospit
treatment
intraven
antibiot
respiratori
indic
respiratori
system
physic
find
record
symptom
survey
complet
particip
record
presenc
absenc
respiratori
symptom
visit
preced
day
sputum
bacteri
cultur
result
also
record
nasal
sampl
oropharyng
op
swab
collect
visit
particip
abl
expector
sputum
also
collect
nasal
sampl
consist
either
nasal
wash
deep
nasal
swab
place
specimen
lysi
buffer
subsequ
collect
op
swab
place
nasal
wash
lysi
buffer
upper
airway
sampl
reflect
combin
nasal
op
specimen
sampl
store
frozen
process
viral
test
nucleic
acid
extract
sampl
either
upper
airway
sputum
amplifi
specif
primer
detect
common
respiratori
virus
respiratori
syncyti
viru
influenza
viru
type
b
parainfluenza
viru
type
human
metapneumoviru
human
coronavirus
subtyp
rhinovirus
adenovirus
specimen
test
panel
seven
singl
multiplex
realtim
revers
transcript
rt
pcr
pcr
adenoviru
qualit
detect
respiratori
virus
previous
describ
upper
airway
sampl
extract
previous
describ
sputum
dilut
sputolysin
mm
dithiothreitol
extract
use
qiaamp
rna
mini
kit
qiagen
inc
frederick
md
usa
sampl
elut
water
exo
rna
ad
lysi
buffer
extract
amplif
control
assay
reliabl
detect
viral
copi
per
reaction
provid
sensit
copi
ml
specimen
ad
per
reaction
rtpcr
mix
premad
ad
correct
amount
specif
primer
probe
seven
reaction
tube
dri
store
frozen
month
amplif
onestep
rtpcr
master
mix
agpath
appli
biosystem
foster
citi
ca
usa
extract
sampl
ad
sevenwel
set
result
report
posit
amplif
plot
cross
threshold
cycl
neg
amplif
plot
cross
threshold
target
well
sampl
neg
respiratori
virus
averag
exo
threshold
cycl
unsatisfactori
extract
amplif
repeat
new
rhinoviru
assay
detect
rhinoviru
subtyp
detect
origin
assay
introduc
studi
extract
nucleic
acid
sampl
store
month
thaw
retrospect
test
new
assay
major
sampl
studi
date
purpos
data
analysi
defin
posit
rhinoviru
result
posit
find
either
assay
comparison
pair
sampl
pair
judg
use
version
assay
frequenc
viru
detect
upper
airway
sputum
sampl
summar
count
proport
repeat
measur
regress
model
account
repeat
observ
per
particip
use
analyz
concord
pair
sampl
depend
variabl
reflect
whether
result
within
sampl
pair
differ
sensit
specif
sputum
sampl
viru
detect
rel
upper
airway
sampl
refer
standard
estim
proport
associ
confid
interv
ci
estim
obtain
use
sandwich
estim
varianc
logist
regress
model
account
repeat
observ
per
particip
potenti
predictor
respiratori
viru
detect
concurr
respiratori
ill
blackwel
publish
ltd
ness
respiratori
sign
symptom
bacteri
cultur
result
examin
logist
regress
model
adjust
age
account
repeat
observ
per
particip
estim
odd
ratio
ci
pvalu
obtain
model
report
pvalu
adjust
multipl
comparison
analys
perform
use
stata
releas
statacorp
colleg
station
tx
usa
total
particip
enrol
mean
age
enrol
year
mean
fev
percent
predict
tabl
upper
airway
sampl
collect
visit
studi
period
averag
sampl
per
particip
sd
rang
nasal
sampl
collect
nasal
swab
rather
nasal
wash
particip
prefer
pair
sputum
specimen
collect
simultan
upper
airway
sampl
particip
abl
expector
one
visit
studi
subcohort
expector
patient
similar
total
cohort
term
demograph
lower
bmi
percentil
wors
lung
function
enrol
observ
full
cohort
tabl
pair
sputum
sampl
collect
visit
howev
sampl
six
visit
could
assay
four
failur
amplifi
two
miss
thu
pair
sputum
sampl
avail
visit
character
pulmonari
exacerb
among
upper
airway
sampl
test
pcr
least
one
respiratori
viru
detect
sampl
two
respiratori
virus
detect
six
specimen
averag
number
posit
upper
airway
sampl
per
particip
sd
rang
rhinoviru
commonli
detect
viru
found
sampl
result
addit
virus
summar
tabl
among
studi
particip
least
one
posit
upper
airway
sampl
followup
thirtynin
particip
rhinoviru
detect
one
visit
includ
particip
rhinoviru
detect
twice
rhinoviru
detect
three
visit
total
eight
visit
proport
visit
rhinoviru
detect
highest
fourth
quarter
year
versu
first
third
quarter
respect
among
visit
pair
sputum
sampl
also
collect
rhinovirus
commonli
detect
viru
detect
rate
sampl
type
tabl
viru
type
combin
p
p
respect
estim
sensit
specif
sputum
sampl
rhinoviru
detect
rel
detect
upper
airway
sampl
observ
sensit
ci
specif
ci
estim
sensit
specif
calcul
viru
type
low
rel
frequenc
rhinoviru
preval
viru
type
detect
studi
analys
examin
rhinoviru
detect
associ
clinic
paramet
analys
restrict
subset
upper
airway
sampl
rhinoviru
viru
detect
n
virus
detect
n
sampl
isol
viru
type
n
coisol
rhinoviru
anoth
viru
type
n
exclud
among
visit
give
rise
sampl
visit
character
respiratori
ill
requir
antibiot
treatment
intraven
inhal
antibiot
pulmonari
exacerb
antibiot
treatment
respiratoryrel
ill
rhinoviru
detect
respiratori
ill
visit
nonil
visit
find
logist
regress
model
signific
associ
respiratori
ill
concurr
detect
rhinoviru
ci
p
respiratori
ill
requir
antibiot
treatment
day
prior
studi
visit
includ
associ
detect
rhinoviru
slightli
stronger
ci
p
among
respiratori
sign
record
visit
rhinorrhea
ci
p
abnorm
chest
exam
ci
p
posit
associ
upper
airway
detect
rhinoviru
among
concurr
respiratori
symptom
collect
particip
selfreport
increas
cough
increas
nasal
congest
increas
sputum
product
wheez
signific
predictor
rhinoviru
detect
tabl
increas
cough
increas
sputum
product
predict
rhinoviru
detect
among
symptom
bacteri
cultur
result
also
evalu
determin
whether
concurr
cultur
posit
pseudomona
aeruginosa
staphylococcu
aureu
associ
upper
airway
rhinoviru
detect
among
visit
concurr
cultur
data
avail
aureu
posit
cultur
associ
rhinoviru
detect
ci
p
howev
p
aeruginosa
posit
cultur
ci
p
evalu
respiratori
virus
specimen
children
cf
use
sensit
specif
molecular
method
detect
recent
report
punch
et
al
evalu
rtpcr
detect
seven
common
respiratori
virus
cf
sputum
olesen
et
al
evalu
pcr
detect
either
laryng
aspir
sputum
without
pair
sampl
upper
airway
studi
evalu
rel
frequenc
respiratori
virus
nasal
swab
cf
individu
without
evalu
presenc
sputum
uniqu
aspect
current
studi
includ
evalu
addit
novel
virus
includ
human
metapneumoviru
divers
strain
coronavirus
examin
potenti
associ
viral
detect
patientreport
symptom
clinic
sign
prospect
evalu
pair
upper
airway
sputum
sampl
children
cf
demonstr
pcr
detect
respiratori
virus
upper
airway
sputum
sampl
similar
rate
find
discord
result
associ
sampl
type
note
detect
virus
singl
specimen
demonstr
increas
level
viral
detect
compar
report
use
viral
cultur
result
combin
previou
report
demonstr
use
molecular
detect
virus
children
cf
despit
larg
number
respiratori
virus
detect
respiratori
viral
panel
major
virus
identifi
throughout
studi
upper
airway
sputum
specimen
children
cf
rhinovirus
overal
particip
rhinoviru
detect
respiratori
sampl
followup
true
whether
particip
symptomat
sever
recent
studi
use
similar
molecular
method
evalu
respiratori
virus
sputum
nasal
op
sampl
found
far
greater
sensit
rhinoviru
use
rtpcr
compar
cultur
danish
studi
children
cf
follow
year
rhinovirus
detect
least
patient
surpris
rhinovirus
commonli
detect
children
cf
common
virus
detect
similarli
age
healthi
pediatr
popul
improv
pcr
techniqu
util
rhinovirus
increasingli
associ
substanti
respiratori
diseas
caus
hospit
young
children
sever
diseas
immunocompromis
host
rhinovirus
also
associ
increas
diseas
sever
lower
respiratori
symptom
individu
asthma
compar
healthi
control
use
clinic
inform
collect
studi
found
rhinorrhea
abnorm
chest
examin
associ
rhinoviru
detect
increas
cough
sputum
product
predict
rhinoviru
among
symptom
report
patient
exploratori
analys
current
cf
cohort
inconclus
associ
rhinoviru
respiratoryrel
ill
differ
find
wat
et
al
uk
detect
rhinovirus
sampl
obtain
routin
clinic
visit
obtain
exacerb
p
suggest
associ
rhinoviru
pulmonari
exacerb
discrep
result
may
reflect
studi
design
smaller
studi
popul
versu
particip
rel
less
frequent
sampl
quarterli
versu
everi
month
addit
uk
studi
includ
children
age
wherea
studi
exclud
patient
year
age
might
expect
rhinovirus
commonli
associ
pulmonari
exacerb
younger
children
includ
studi
hospit
children
five
cf
demonstr
rate
rhinovirusassoci
hospit
per
children
much
higher
rate
histori
wheez
asthma
hospit
children
detect
rhinovirus
symptomat
asymptomat
subject
rais
possibl
prolong
viral
shed
children
cf
prolong
shed
children
asthma
exampl
previous
report
sever
studi
howev
follow
patient
routin
quarterli
clinic
visit
techniqu
type
rhinovirus
definit
document
prolong
shed
versu
multipl
reinfect
singl
differ
rhinoviru
subtyp
potenti
limit
current
studi
includ
rel
small
sampl
size
exclus
young
children
highest
rate
viral
preval
sputum
sampl
use
assess
viral
shed
lower
airway
use
invas
procedur
bronchoalveolar
lavag
could
justifi
studi
question
contamin
sputum
sampl
respiratori
virus
upper
airway
anoth
potenti
concern
howev
distribut
concord
discord
sampl
argu
final
frequenc
sampl
chosen
reflect
current
clinic
practic
guidelin
suffici
frequent
detect
viral
infect
earli
cours
studi
provid
evid
pcrbase
viral
detect
allow
rapid
accur
diagnosi
viral
infect
children
cf
result
also
suggest
sampl
either
upper
airway
sputum
perform
well
viru
detect
rhinoviru
preval
respiratori
viru
detect
might
expect
children
age
recent
studi
demonstr
import
shortterm
longterm
impact
rhinoviru
children
without
underli
lung
diseas
emphas
impact
viru
suggest
need
reexamin
impact
children
young
adult
cf
